Yojiro Arinobu

Lecturer

National University Corporation Kyushu University, Clinical Immunology & Rheumatology/Infectious Disease

Websitehttp://hyoka.ofc.kyushu-u.ac.jp/search/details/K003497/index.html

3103 Citations
25 h-Index

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yojiro Arinobu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

18 Similar Profiles

Hematopoietic Stem Cells Medicine & Life Sciences

Interleukin-4 Medicine & Life Sciences

Systemic Lupus Erythematosus Medicine & Life Sciences

Monocytes Medicine & Life Sciences

Mast Cells Medicine & Life Sciences

Interleukin-10 Medicine & Life Sciences

B-Lymphocytes Medicine & Life Sciences

Hematopoiesis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

3103 Citations
25 h-Index
47 Article
2 Letter
2 Review article

1 Citation (Scopus)

Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?

Tada, Y., Inokuchi, S., Maruyama, A., Suematsu, R., Sakai, M., Sadanaga, Y., Ono, N., Arinobu, Y. & Koarada, S., Jan 18 2019, In : Rheumatology International. 39, 1, p. 97-104 8 p.

Research output: Contribution to journal › Article

Macrophage Activation Syndrome

Adult-Onset Still's Disease

Juvenile Arthritis

Sensitivity and Specificity

Triglycerides

CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: A post hoc analysis of a phase I/II clinical trial conducted in Japan

Ayano, M., Tsukamoto, H., Mitoma, H., kimoto, Y., Akahoshi, M., Arinobu, Y., Miyamoto, T., Horiuchi, T., Niiro, H., Nagafuji, K., Harada, M. & Akashi, K., Jan 22 2019, In : Arthritis Research and Therapy. 21, 1, 30.

Research output: Contribution to journal › Article

Phase II Clinical Trials

Clinical Trials, Phase I

Systemic Scleroderma

Hematopoietic Stem Cell Transplantation

Japan

Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis

Fukui, S., Kuwahara-Takaki, A., Ono, N., Sato, S., Koga, T., Kawashiri, S. Y., Iwanaga, N., Iwamoto, N., Ichinose, K., Tamai, M., Nakamura, H., Origuchi, T., Migita, K., Arinobu, Y., Niiro, H., Tada, Y., Akashi, K., Maeda, T. & Kawakami, A., Dec 1 2019, In : Scientific reports. 9, 1, 688.

Research output: Contribution to journal › Article

Takayasu Arteritis

Giant Cell Arteritis

Fibroblast Growth Factor 2

Granulocyte-Macrophage Colony-Stimulating Factor

Serum

4 Citations (Scopus)

Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study

Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., Niiro, H., Akashi, K. & Horiuchi, T., Apr 1 2018, In : PloS one. 13, 4, e0196368.

Research output: Contribution to journal › Article

glycohemoglobin

rheumatoid arthritis

tumor necrosis factors

Glycosylated Hemoglobin A

observational studies

Notch1 expression is regulated at the post-transcriptional level by the 3′ untranslated region in hematopoietic stem cell development

Mizuno, S., Iino, T., Ozawa, H., Arinobu, Y., Jeong, Y. & Akashi, K., Mar 1 2018, In : International Journal of Hematology. 107, 3, p. 311-319 9 p.

Research output: Contribution to journal › Article

3' Untranslated Regions

Hematopoietic Stem Cells

Hematopoiesis

Messenger RNA

Essential Genes